July 10, 2026

• 12:04 PM · Pharmaceutical Executive
  12:04 PM<![CDATA[FDA Pauses Release of New CRL’s Following Citizen’s Petition ]]> — Pharmaceutical Executive
• 12:00 PM · BioWorld
  12:00 PMFormer Astrazeneca employee settles insider trading charges — BioWorld
• 11:42 AM · BioPharma Dive
  11:42 AMGSK, Hansoh ADC extends survival in lung cancer study — BioPharma Dive
• 10:08 AM · Pharmaceutical Executive
  10:08 AM<![CDATA[FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma ]]> — Pharmaceutical Executive
• 9:00 AM · BioWorld
  9:00 AMRani collaborates with Pegbio on oral drug delivery in obesity — BioWorld
• 9:00 AM · BioWorld
  9:00 AMApertura Gene Therapy enters CRADA for Niemann-Pick disease — BioWorld
• 9:00 AM · BioWorld
  9:00 AMFate Therapeutics’ FT-839 gains IND clearance — BioWorld
• 9:00 AM · BioWorld
  9:00 AMAtsena selects ATSN-401 clinical candidate for Stargardt disease — BioWorld
• 6:46 AM · Pharmaceutical Technology
  6:46 AMChinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA — Pharmaceutical Technology
• 6:32 AM · Pharmaceutical Technology
  6:32 AMIpsen set to rival Botox after duo of Phase III migraine wins — Pharmaceutical Technology
• 6:00 AM · Pharmaceutical Executive
  6:00 AM<![CDATA[U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels]]> — Pharmaceutical Executive
• 5:31 AM · Pharmaceutical Technology
  5:31 AMTeva and Polpharma Biologics sign global deal for ocrelizumab biosimilar — Pharmaceutical Technology
• 4:59 AM · Drug Discovery World
  4:59 AMAlchemab receives £25 million from British Business Bank — Drug Discovery World
• 4:47 AM · FT — Pharmaceuticals
  4:47 AMBayer sells stake in contraceptives business to Apollo in €3bn financing deal — FT — Pharmaceuticals